CDNA

CareDx (CDNA)

CareDx Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CDNA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/01/13	21 : 00	Business Wire	CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results	NASDAQ:CDNA	CareDx Inc
2025/01/11	11 : 46	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:CDNA	CareDx Inc
2025/01/11	11 : 46	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:CDNA	CareDx Inc
2025/01/09	06 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDNA	CareDx Inc
2025/01/09	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDNA	CareDx Inc
2024/12/18	21 : 05	Business Wire	CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference	NASDAQ:CDNA	CareDx Inc
2024/12/11	21 : 00	Business Wire	CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy	NASDAQ:CDNA	CareDx Inc
2024/12/11	21 : 00	PR Newswire (US)	TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy	NASDAQ:CDNA	CareDx Inc
2024/12/07	06 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDNA	CareDx Inc
2024/12/05	06 : 42	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CDNA	CareDx Inc
2024/12/04	10 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDNA	CareDx Inc
2024/12/04	06 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDNA	CareDx Inc
2024/11/27	06 : 25	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CDNA	CareDx Inc
2024/11/26	06 : 45	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CDNA	CareDx Inc
2024/11/19	07 : 11	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CDNA	CareDx Inc
2024/11/18	21 : 00	Business Wire	Gestion mondiale d’actifs CI annonce un nombre de fusions de fonds communs de placement et de FNB et une modification de la cote de risque	NASDAQ:CDNA	CareDx Inc
2024/11/15	07 : 13	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:CDNA	CareDx Inc
2024/11/12	21 : 05	Business Wire	CareDx to Participate in Upcoming Investor Conferences	NASDAQ:CDNA	CareDx Inc
2024/11/09	06 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDNA	CareDx Inc
2024/11/09	04 : 34	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:CDNA	CareDx Inc
2024/11/06	06 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDNA	CareDx Inc
2024/11/06	06 : 34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDNA	CareDx Inc
2024/11/06	06 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDNA	CareDx Inc
2024/11/05	20 : 07	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:CDNA	CareDx Inc
2024/11/05	06 : 18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CDNA	CareDx Inc
2024/11/05	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDNA	CareDx Inc
2024/11/05	06 : 05	Business Wire	CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance	NASDAQ:CDNA	CareDx Inc
2024/10/23	20 : 00	Business Wire	CareDx and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching with Cutting-Edge Hi-C Technology	NASDAQ:CDNA	CareDx Inc
2024/10/21	20 : 00	Business Wire	CareDx Showcases Latest Advancements Across its HLA Typing Solutions at Annual American Society for Histocompatibility and Immunogenetics Meeting	NASDAQ:CDNA	CareDx Inc
2024/10/15	20 : 56	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDNA	CareDx Inc